N-[2-[4-(1-bicyclo[1.1.1]pentanylamino)sulfanylanilino]-2-oxoethyl]pyridine-3-carboxamide
C19H20N4O2S — CID 156652794
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[2-[4-(1-bicyclo[1.1.1]pentanylamino)sulfanylanilino]-2-oxoethyl]pyridine-3-carboxamide
N-[2-[4-(1-bicyclo[1.1.1]pentanylamino)sulfanylanilino]-2-oxoethyl]pyridine-3-carboxamide (PubChem CID 156652794) has the molecular formula C19H20N4O2S and a molecular weight of 368.46 g/mol. Its IUPAC name is N-[2-[4-(1-bicyclo[1.1.1]pentanylamino)sulfanylanilino]-2-oxoethyl]pyridine-3-carboxamide.
Molecular Properties
| Compound Name | N-[2-[4-(1-bicyclo[1.1.1]pentanylamino)sulfanylanilino]-2-oxoethyl]pyridine-3-carboxamide |
|---|---|
| PubChem CID | 156652794 |
| Molecular Formula | C19H20N4O2S |
| Molecular Weight | 368.46 g/mol |
| Exact Mass | 368.13 |
| IUPAC Name | N-[2-[4-(1-bicyclo[1.1.1]pentanylamino)sulfanylanilino]-2-oxoethyl]pyridine-3-carboxamide |
| SMILES | O=C(CNC(=O)c1cccnc1)Nc1ccc(SNC23CC(C2)C3)cc1 |
| InChI | InChI=1S/C19H20N4O2S/c24-17(12-21-18(25)14-2-1-7-20-11-14)22-15-3-5-16(6-4-15)26-23-19-8-13(9-19)10-19/h1-7,11,13,23H,8-10,12H2,(H,21,25)(H,22,24) |
| InChIKey | OASWNUSZBDEBHD-UHFFFAOYSA-N |
| XLogP | 2.60 |
| TPSA | 83.12 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 26 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 368.46 |
| LogP ≤ 5 | 2.60 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 5 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'sulphur_nitrogen_single_bond', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 156652794 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.